Evaluating Postoperative Prognosis: A Single Surgeon's Experience With Total Mesorectal Excision in Middle and Lower Rectal Cancer Cases in Iraq
- PMID: 38993431
- PMCID: PMC11238923
- DOI: 10.7759/cureus.62174
Evaluating Postoperative Prognosis: A Single Surgeon's Experience With Total Mesorectal Excision in Middle and Lower Rectal Cancer Cases in Iraq
Abstract
Introduction: Surgical intervention for rectal cancer is widely recognized for its potential to significantly impact quality of life, chiefly due to the high probability of permanent colostomy and the associated postoperative complications.
Objective: This study aimed to evaluate the short-term outcomes and morbidity associated with total mesorectal excision for middle and lower rectal cancer within an Iraqi cohort, in a prospective setting.
Methods: This study prospectively collected and analyzed data from 89 patients who underwent a standardized radical rectal resection, with a follow-up period extending to one month post-surgery.
Results: The mean age of patients was 54.4 ± 12.9 years, with a gender distribution of 46 males and 43 females. A total of 33 patients presented with preoperative comorbidities, which heightened the risk of adverse short-term outcomes by a factor of 7.51. The most prevalent comorbidities were hypertension and diabetes mellitus, affecting 22 and 20 patients, respectively. Patients aged 60 years and above were at a 3.97 times greater risk of developing complications. The overall complication rate was 21.35%, with wound infections (9.0%) and cardiovascular events (3.4%) being the most common. Mortality during the follow-up was 1.1%.
Conclusion: The findings indicate that increased age and the presence of comorbidities are significant risk factors for morbidity and mortality post-surgery. Neoadjuvant chemoradiotherapy or radiotherapy was shown to reduce morbidity and mortality rates while improving survival. The morbidity and mortality rates observed in this study concur with existing literature.
Keywords: adenocarcinoma; neoadjuvant therapy; rectal cancer; short-term outcomes; total mesorectal excision.
Copyright © 2024, Mahmood et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. Iraqi Board of Medical Specializations issued approval 916. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Local versus radical surgery for early rectal cancer with or without neoadjuvant or adjuvant therapy.Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD002198. doi: 10.1002/14651858.CD002198.pub3. Cochrane Database Syst Rev. 2023. PMID: 37310167 Free PMC article. Review.
-
[Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jun 25;25(6):522-530. doi: 10.3760/cma.j.cn441530-20210811-00321. Zhonghua Wei Chang Wai Ke Za Zhi. 2022. PMID: 35754217 Chinese.
-
Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.Rev Invest Clin. 2006 May-Jun;58(3):204-10. Rev Invest Clin. 2006. PMID: 16958295
-
[Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Apr 25;24(4):344-351. doi: 10.3760/cma.j.cn.441530-20201204-00644. Zhonghua Wei Chang Wai Ke Za Zhi. 2021. PMID: 33878824 Chinese.
-
Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer.Int J Colorectal Dis. 2020 Apr;35(4):575-593. doi: 10.1007/s00384-020-03545-7. Epub 2020 Mar 2. Int J Colorectal Dis. 2020. PMID: 32124047
References
-
- Global trends in colorectal cancer mortality: projections to the year 2035. Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, Arnold M. Int J Cancer. 2019;144:2992–3000. - PubMed
-
- Australian Cancer Incidence and Mortality (ACIM) Books; 2014. Cancer in Australia 2021.
-
- The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Heald RJ, Husband EM, Ryall RD. Br J Surg. 1982;69:613–616. - PubMed
LinkOut - more resources
Full Text Sources